Maybe - but a lot of this audience may be new to C
Post# of 151747
(Total Views: 581)
Posted On: 04/30/2021 9:42:18 PM
Maybe - but a lot of this audience may be new to CCR5/RANTES as a cancer target, and to LL completely. Was perfectly executed to medical professionals who likely know nothing about this molecule.
Quote:
Would have been a bit more impressive if Kelly did more than just read the slides.
IMO
Read More: https://investorshangout.com/post/view?id=612...z6tZbZKFC8
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼